Patients with implanted heart valves are clinically challenging. Conditions such as increase in valve gradients or regurgitation, and considerations of thrombosis or prosthetic-patient mismatch are relatively common.
Previously implanted heart valves, after cardiac surgery or transcatheter aortic valve replacement (TAVR), may have limited durability and are prone to degeneration. Optimal assessment of these valves by various imaging modalities and defining the optimal timing and mode of treatment of these valves when failed, requires a specialized team in the field of prosthetic heart valve management.
Referring providers have direct access to Danny Dvir, M.D. (firstname.lastname@example.org, 206.598.VALV (8258)) to discuss a specific patient prior to referral. Dr. Dvir is an internationally-recognized leader in the evaluation and treatment of failed surgically inserted valves (valve-in-valve) and is the chairman of the global Valve-in-Valve Registry.